Travere Therapeutics (TVTX) Return on Sales [ROS] (2014 - 2026)
Travere Therapeutics (TVTX) recorded Return on Sales [ROS] of 2.33% in Q2 2026, up 13.38 percentage points from -11.05% a year earlier and up 31.35 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Return on Sales [ROS] (2014 - 2026) Analysis & Trends
On a TTM basis, Travere Therapeutics' Return on Sales [ROS] came in at -6.84% as of Jun 30, 2026, up 44.74 percentage points year-over-year; for FY2025, it came in at -12.80%, up 126.08 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for four straight years, with a five-year change of +76.03 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -138.88% in FY2024 (+128.37 pp), -267.24% in FY2023 (+24.93 pp), -292.17% in FY2022 (+1369.70 pp) and -1661.88% in FY2021 (-1573.05 pp).
- Quarterly Return on Sales [ROS] has ranged from -707.08% in Q4 2021 to 15.12% in Q3 2025 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for nine consecutive quarters, with an average year-over-year change of +110.47 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 411.57 percentage points in Q4 2022, against a drop of 474.55 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -29.02% (Q1 2026), -25.00% (Q4 2025) and 15.12% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Travere Therapeutics | 5.36 Bn | 4.96 Bn | 167.41 Mn | 2.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33% |
| Mar 31, 2026 | -29.02% |
| Dec 31, 2025 | -25.00% |
| Sep 30, 2025 | 15.12% |
| Jun 30, 2025 | -11.05% |
| Mar 31, 2025 | -52.21% |
| Dec 31, 2024 | -81.21% |
| Sep 30, 2024 | -89.27% |
| Jun 30, 2024 | -125.11% |
| Mar 31, 2024 | -336.53% |
| Dec 31, 2023 | -209.13% |
| Sep 30, 2023 | -249.59% |
| Jun 30, 2023 | -322.87% |
| Mar 31, 2023 | -315.23% |
| Dec 31, 2022 | -295.52% |
| Sep 30, 2022 | -294.23% |
| Jun 30, 2022 | -274.24% |
| Mar 31, 2022 | -307.45% |
| Dec 31, 2021 | -707.08% |
| Sep 30, 2021 | -46.49% |
API Access
Travere Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();